Chemical Biology, Nano Drug Delivery Systems (NDDS), Bio-Innovation Center (BIC), Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala 695014, India,
Int J Nanomedicine. 2019 Mar 29;14:2253-2263. doi: 10.2147/IJN.S190321. eCollection 2019.
Treatment of wounds with the help of nanoparticles (NPs) is more effective and superior in comparison to traditional wound healing methods as it protects and sustains active drug release at the wound site thus enhancing the safety of the drug and reducing the possibility of side effects. The advantages of this method are the possibility of allowing a reduction in administered dose, limiting toxicity levels to the minimum, and increasing safety of topical delivery of the drug.
We report the synthesis of a novel poly (lactic-co-glycolic acid) (PLGA) NP-based multicargo delivery system for growth factors and antimicrobial peptide. Growth factors vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were entrapped in PLGA NPs by solvent diffusion method and an antimicrobial peptide (K4) was conjugated to the NP by carbodiimide chemistry. The developed multiple cargo delivery systems with growth factors (VEGF and bFGF) and an antimicrobial peptide (K4) were investigated and optimized for potential wound healing.
The system showed a sustained release of growth factors and was evaluated for cytotoxicity by MTT and live/dead assay, which revealed that the bioactivity of the growth factor-entrapped NPs was higher than that of free growth factors, and it also induced enhanced cell proliferation in vitro.
The development of a system for the codelivery of growth factors (VEGF and bFGF) and an antimicrobial peptide (K4) was investigated for potential wound healing application. The entrapment of growth factors with very high efficiency is an advantage in this method along with its sustained release from the nanoparticulate system, which will enhance the angiogenesis. Our system also displayed broad-spectrum antimicrobial activity against both gram-positive and gram-negative bacteria.
与传统的伤口愈合方法相比,利用纳米颗粒(NPs)治疗伤口更有效、更优越,因为它可以保护和维持活性药物在伤口部位释放,从而提高药物的安全性并降低副作用的可能性。这种方法的优点是有可能减少给药剂量,将毒性水平降至最低,并提高药物的局部递送安全性。
我们报告了一种新型聚(乳酸-共-乙醇酸)(PLGA)NP 基多载药系统的合成,用于生长因子和抗菌肽。通过溶剂扩散法将血管内皮生长因子(VEGF)和碱性成纤维细胞生长因子(bFGF)包封在 PLGA NPs 中,并通过碳二亚胺化学将抗菌肽(K4)偶联到 NP 上。开发了具有生长因子(VEGF 和 bFGF)和抗菌肽(K4)的多载药系统,并对其进行了优化,以用于潜在的伤口愈合。
该系统表现出生长因子的持续释放,并通过 MTT 和活/死测定进行了细胞毒性评估,结果表明,包封在 NP 中的生长因子的生物活性高于游离生长因子,并且还能诱导体外细胞增殖。
研究了一种用于共递送生长因子(VEGF 和 bFGF)和抗菌肽(K4)的系统,以用于潜在的伤口愈合应用。该方法的一个优点是能够非常高效地包封生长因子,并且其从纳米颗粒系统中的持续释放将增强血管生成。我们的系统还对革兰氏阳性和革兰氏阴性细菌表现出广谱抗菌活性。